SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* Werner Martin (Last) (First) (Middle) C/O DD3 ACQUISITION CORP. PEDREGAL 24, COLONIA MOLINO DEL REY (Street) MEXICO CITY O5 11040 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol DD3 Acquisition Corp. [ DDMX ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director X 10% Owner X Officer (give title below) Other (specify below) Chairman and CEO
	3. Date of Earliest Transaction (Month/Day/Year) 07/02/2019
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	07/02/2019		S		430,800	D	$0.0174	1,199,575	I	See footnote(1)
Ordinary Shares	07/02/2019		S		430,800	D	$0.0174	768,775	I	See footnote(1)
Ordinary Shares	07/02/2019		S		135,702	D	$0.0174	633,073	I	See footnote(1)
Ordinary Shares	07/02/2019		S		79,698	D	$0.0174	553,375	I	See footnote(1)
Ordinary Shares	07/02/2019		S		269,250	D	$0.0174	284,125	I	See footnote(1)
Ordinary Shares	07/02/2019		S		25,000	D	$0.0174	259,125	I	See footnote(1)
Ordinary Shares	07/02/2019		S		5,000	D	$0.0174	254,125	I	See footnote(1)
Ordinary Shares	07/02/2019		S		5,000	D	$0.0174	249,125	I	See footnote(1)
Ordinary Shares	07/02/2019		S		5,000	D	$0.0174	244,125	I	See footnote(1)
Ordinary Shares	07/02/2019		S		5,000	D	$0.0174	239,125	I	See footnote(1)
Ordinary Shares	07/02/2019		S		47,825	D	(2)	191,300	I	See footnote(1)
Ordinary Shares	07/02/2019		P		430,800(3)	A	$0.0174	430,800	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Warrant	$11.5	07/02/2019		S			47,825	(4)	(5)	Ordinary Shares	47,825	(2)	191,300	I	See footnote(1)

Explanation of Responses:

1. The securities are held directly by DD3 Mex Acquisition Corp (the "Sponsor") and indirectly by Dr. Martin M. Werner and Jorge Combe, each of whom shares voting power with respect to the Sponsor. Certain of the Issuer's other officers and directors hold economic interests in the Sponsor and pecuniary interests in certain of the securities held by the Sponsor. Each of Dr. Werner, Mr. Combe and such other officers and directors disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

2. Pursuant to an assignment agreement by and between the Sponsor and Dr. Guillermo Ortiz, 47,825 units ("Private Units") were transferred to Dr. Ortiz at a price of $10.00 per Private Unit. Each Private Unit consists of one ordinary share and one warrant.

3. Represents 430,800 shares previously held through the Sponsor, which were transferred to Dr. Werner pursuant to an assignment agreement by and between the Sponsor and Dr. Werner, that are now owned directly by Dr. Werner.

4. The warrants will become exercisable on the later of 30 days after the completion of the Issuer's initial business combination or October 16, 2019.

5. The warrants expire five years after the completion of the Issuer's initial business combination or earlier upon redemption or liquidation.

	/s/ Alan I. Annex, Attorney-in-Fact	07/03/2019
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.